Ipca Labs.
Drug Manufacturers - Specialty & Generic · IPCALAB
Large CapHealthcareMature Stable
Pranay Godha
Managing Director and CEO · Pragmatic
Company DNA
Hierarchical
About
Ipca Labs. is a Large Cap company in the Healthcare sector, listed on NSE as IPCALAB. With a market cap of ₹38K Cr and revenue of ₹9K Cr, it is currently in the Mature Stable phase. Known for its Hierarchical culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Stable, long-established pharmaceutical entity with a traditional corporate hierarchy and focus on steady execution. Its strategic mandate: To sustain growth in international markets, the company needs a leader focused on navigating complex global regulatory frameworks and compliance standards.
FAQ
What kind of company is Ipca Labs.?
Ipca Labs. is a Large Cap Healthcare company (IPCALAB) in the Mature Stable phase with a market cap of ₹38K Cr. It is classified as Hierarchical in culture.
What is Ipca Labs.'s culture and work environment like?
Ipca Labs. has a Hierarchical culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: B2B-Enterprise. Stable, long-established pharmaceutical entity with a traditional corporate hierarchy and focus on steady execution.
Who leads Ipca Labs.?
Ipca Labs. is led by Pranay Godha (Managing Director and CEO), a Pragmatic leader with 22 years of experience.
What are Ipca Labs.'s financials?
Ipca Labs. reported revenue of ₹9K Cr in FY25 with a 5-year revenue CAGR of 15.4%. Operating margin: 15.3%. Market cap: ₹38K Cr.
Culture & Strategy
CultureHierarchical
InnovationFast-Follower
PaceSteady-Marathon
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployeeSteady Employer
BrandTechnical-Expert
LifecycleMature Stable
Stable, long-established pharmaceutical entity with a traditional corporate hierarchy and focus on steady execution.
Mandate
To sustain growth in international markets, the company needs a leader focused on navigating complex global regulatory frameworks and compliance standards.
To sustain growth in international markets, the company needs a leader focused on navigating complex global regulatory frameworks and compliance standards.
Financials
Revenue FY25₹9K Cr
PAT FY25₹738 Cr
Rev CAGR 5Y15.4%
OPM15.3%
NPM8.3%
ROE10.6%
ROCE14.5%
P/E43.5
Fwd P/E28.9
P/B4.8
D/E14.4
Mkt Cap₹38K Cr
Promoter45.1%
Institutional46.6%
Similar Culture
Could You Lead Ipca Labs.?
Take the Genome Benchmark →